Perspective Therapeutics, Inc. Research And Development Expense

• Perspective Therapeutics, Inc. showed an increase of +102.3% in Research And Development Expense from 2024 to 2025.
• This data is from Perspective Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
• XBRL data for this metric is available from 2012 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 15 years of available data (2012 to 2025), Perspective Therapeutics, Inc.'s Research And Development Expense has grown by 10,688.8%.
• Historical annual values: Fiscal year 2025: $84.22 million | Fiscal year 2024: $41.64 million | Fiscal year 2023: $21.31 million | Fiscal year 2022: $881.0 thousand | Fiscal year 2022: $850.0 thousand | Fiscal year 2021: $1.43 million | Fiscal year 2020: $1.13 million | Fiscal year 2019: $1.47 million | Fiscal year 2018: $1.75 million | Fiscal year 2017: $965.0 thousand | Fiscal year 2016: $528.0 thousand | Fiscal year 2015: $615.0 thousand | Fiscal year 2014: $668.8 thousand | Fiscal year 2013: $627.1 thousand | Fiscal year 2012: $780.6 thousand.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026